Current practices and future outlook on the integration of biomarkers in the drug development process. | Bioanalysis;9(22): 1827-1837, 2017 Nov. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Current practices and future outlook on the integration of biomarkers in the drug development process.

Fraser, Stephanie; Osgood, Sarah.

Affiliation

Fraser S; Pfizer, Eastern Point Rd., Groton, CT 06340, USA.
Osgood S; Pfizer, Eastern Point Rd., Groton, CT 06340, USA.

Bioanalysis ; 9(22): 1827-1837, 2017 Nov.

Article in En | MEDLINE | ID: mdl-29120222

Subject(s)
Key words

animal model; assay validation; biomarker; biomarker qualification; biomarker specificity; context of use; sensitivity; translational biomarker

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Drug Discovery Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Bioanalysis Year: 2017 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Drug Discovery Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Animals / Humans Language: En Journal: Bioanalysis Year: 2017 Document type: Article Affiliation country: Country of publication: